Literature DB >> 23354416

Right ventricular systolic pressure measurements in combination with harvest of lung and immune tissue samples in mice.

Wen-Chi Chen1, Sung-Hyun Park, Carol Hoffman, Cecil Philip, Linda Robinson, James West, Gabriele Grunig.   

Abstract

The function of the right heart is to pump blood through the lungs, thus linking right heart physiology and pulmonary vascular physiology. Inflammation is a common modifier of heart and lung function, by elaborating cellular infiltration, production of cytokines and growth factors, and by initiating remodeling processes. Compared to the left ventricle, the right ventricle is a low-pressure pump that operates in a relatively narrow zone of pressure changes. Increased pulmonary artery pressures are associated with increased pressure in the lung vascular bed and pulmonary hypertension. Pulmonary hypertension is often associated with inflammatory lung diseases, for example chronic obstructive pulmonary disease, or autoimmune diseases. Because pulmonary hypertension confers a bad prognosis for quality of life and life expectancy, much research is directed towards understanding the mechanisms that might be targets for pharmaceutical intervention. The main challenge for the development of effective management tools for pulmonary hypertension remains the complexity of the simultaneous understanding of molecular and cellular changes in the right heart, the lungs and the immune system. Here, we present a procedural workflow for the rapid and precise measurement of pressure changes in the right heart of mice and the simultaneous harvest of samples from heart, lungs and immune tissues. The method is based on the direct catheterization of the right ventricle via the jugular vein in close-chested mice, first developed in the late 1990s as surrogate measure of pressures in the pulmonary artery. The organized team-approach facilitates a very rapid right heart catheterization technique. This makes it possible to perform the measurements in mice that spontaneously breathe room air. The organization of the work-flow in distinct work-areas reduces time delay and opens the possibility to simultaneously perform physiology experiments and harvest immune, heart and lung tissues. The procedural workflow outlined here can be adapted for a wide variety of laboratory settings and study designs, from small, targeted experiments, to large drug screening assays. The simultaneous acquisition of cardiac physiology data that can be expanded to include echocardiography and harvest of heart, lung and immune tissues reduces the number of animals needed to obtain data that move the scientific knowledge basis forward. The procedural workflow presented here also provides an ideal basis for gaining knowledge of the networks that link immune, lung and heart function. The same principles outlined here can be adapted to study other or additional organs as needed.

Entities:  

Mesh:

Year:  2013        PMID: 23354416      PMCID: PMC3582655          DOI: 10.3791/50023

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  28 in total

1.  Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension.

Authors:  Ly Tu; Laurence Dewachter; Benoit Gore; Elie Fadel; Philippe Dartevelle; Gérald Simonneau; Marc Humbert; Saadia Eddahibi; Christophe Guignabert
Journal:  Am J Respir Cell Mol Biol       Date:  2010-10-29       Impact factor: 6.914

2.  Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice.

Authors:  Yanli Song; Laura Coleman; Jianru Shi; Hideyuki Beppu; Kaori Sato; Kenneth Walsh; Joseph Loscalzo; Ying-Yi Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-13       Impact factor: 4.733

3.  Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension.

Authors:  Syed H E Zaidi; Xiao-Mang You; Sorana Ciura; Mansoor Husain; Marlene Rabinovitch
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

4.  Attenuation of leukocyte recruitment via CXCR1/2 inhibition stops the progression of PAH in mice with genetic ablation of endothelial BMPR-II.

Authors:  Victoria J Burton; Alan M Holmes; Loredana I Ciuclan; Alexander Robinson; Jan S Roger; Gabor Jarai; Andrew C Pearce; David C Budd
Journal:  Blood       Date:  2011-09-07       Impact factor: 22.113

5.  Pulmonary hypertension and right heart failure in pituitary adenylate cyclase-activating polypeptide type I receptor-deficient mice.

Authors:  Christiane Otto; Lutz Hein; Marc Brede; Roland Jahns; Stefan Engelhardt; Hermann-Josef Gröne; Günther Schütz
Journal:  Circulation       Date:  2004-11-01       Impact factor: 29.690

6.  Pulmonary hypertension in TNF-alpha-overexpressing mice is associated with decreased VEGF gene expression.

Authors:  Masaki Fujita; Robert J Mason; Carleyne Cool; John M Shannon; Nobuyuki Hara; Karen A Fagan
Journal:  J Appl Physiol (1985)       Date:  2002-08-09

7.  Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle.

Authors:  James West; Karen Fagan; Wolfgang Steudel; Brian Fouty; Kirk Lane; Julie Harral; Marloes Hoedt-Miller; Yuji Tada; John Ozimek; Rubin Tuder; David M Rodman
Journal:  Circ Res       Date:  2004-03-18       Impact factor: 17.367

8.  Praziquantel reverses pulmonary hypertension and vascular remodeling in murine schistosomiasis.

Authors:  Alexi Crosby; Frances M Jones; Ewa Kolosionek; Mark Southwood; Ian Purvis; Elaine Soon; Ghazwan Butrous; David E Dunne; Nicholas W Morrell
Journal:  Am J Respir Crit Care Med       Date:  2011-08-15       Impact factor: 21.405

9.  Maternal tobacco smoke exposure and persistent pulmonary hypertension of the newborn.

Authors:  C Bearer; R K Emerson; M A O'Riordan; E Roitman; C Shackleton
Journal:  Environ Health Perspect       Date:  1997-02       Impact factor: 9.031

10.  The angiopietin-1-Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice.

Authors:  Lakshmi Kugathasan; Julie Basu Ray; Yupu Deng; Effat Rezaei; Daniel J Dumont; Duncan J Stewart
Journal:  J Exp Med       Date:  2009-09-08       Impact factor: 14.307

View more
  9 in total

1.  Bone Marrow-Derived Proangiogenic Cells Mediate Pulmonary Arteriole Stiffening via Serotonin 2B Receptor Dependent Mechanism.

Authors:  Nathaniel C Bloodworth; Cynthia R Clark; James D West; J Caleb Snider; Christa Gaskill; Sheila Shay; Christine Scott; Julie Bastarache; Santhi Gladson; Christy Moore; Reid D'Amico; Evan L Brittain; Harikrishna Tanjore; Timothy S Blackwell; Susan M Majka; W David Merryman
Journal:  Circ Res       Date:  2018-12-07       Impact factor: 17.367

Review 2.  Perspective: ambient air pollution: inflammatory response and effects on the lung's vasculature.

Authors:  Gabriele Grunig; Leigh M Marsh; Nafiseh Esmaeil; Katelin Jackson; Terry Gordon; Joan Reibman; Grazyna Kwapiszewska; Sung-Hyun Park
Journal:  Pulm Circ       Date:  2014-03       Impact factor: 3.017

3.  Interleukin 13- and interleukin 17A-induced pulmonary hypertension phenotype due to inhalation of antigen and fine particles from air pollution.

Authors:  Sung-Hyun Park; Wen-Chi Chen; Nafiseh Esmaeil; Benjamin Lucas; Leigh M Marsh; Joan Reibman; Gabriele Grunig
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

4.  New mouse model of pulmonary hypertension induced by respiratory syncytial virus bronchiolitis.

Authors:  Dai Kimura; Jordy Saravia; Sridhar Jaligama; Isabella McNamara; Luan D Vu; Ryan D Sullivan; Salvatore Mancarella; Dahui You; Stephania A Cormier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-15       Impact factor: 4.733

5.  The Effects of Antigen-Specific IgG1 Antibody for the Pulmonary-Hypertension-Phenotype and B Cells for Inflammation in Mice Exposed to Antigen and Fine Particles from Air Pollution.

Authors:  Sung-Hyun Park; Wen-Chi Chen; Nedim Durmus; Bertram Bleck; Joan Reibman; Gabriela Riemekasten; Gabriele Grunig
Journal:  PLoS One       Date:  2015-06-16       Impact factor: 3.240

6.  Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension.

Authors:  James D West; Erica J Carrier; Nathaniel C Bloodworth; Alison K Schroer; Peter Chen; Larisa M Ryzhova; Santhi Gladson; Sheila Shay; Joshua D Hutcheson; W David Merryman
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

7.  Elevated microRNA-135a is associated with pulmonary arterial hypertension in experimental mouse model.

Authors:  Hyun-Wook Lee; Sung-Hyun Park
Journal:  Oncotarget       Date:  2017-05-30

8.  Cannabidiol attenuates pulmonary arterial hypertension by improving vascular smooth muscle cells mitochondrial function.

Authors:  Xiaohui Lu; Jingyuan Zhang; Huijiao Liu; Wenqiang Ma; Leo Yu; Xin Tan; Shubin Wang; Fazheng Ren; Xiru Li; Xiangdong Li
Journal:  Theranostics       Date:  2021-03-11       Impact factor: 11.556

9.  Modification of hemodynamic and immune responses to exposure with a weak antigen by the expression of a hypomorphic BMPR2 gene.

Authors:  Sung-Hyun Park; Wen-Chi Chen; Carol Hoffman; Leigh M Marsh; James West; Gabriele Grunig
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.